Marc Beer is a man on a mission. In August 2016, he co-founded the company Renovia and raised over $42 million to get it off the ground. Beer brings over 25 years of experience in biotechnology, pharmaceuticals, and other various facets of medtech. Unsurprisingly, this isn’t Beer’s first rodeo. In fact, he founded the biotech company ViaCell in 2000. ViaCell saw such successful growth that it was bought out by PerkinElmer in 2007. Marc Beer’s list of experience also includes being on the Board of Directors at ErytechPharma, Vice President of Global Marketing at Genzyme, and various roles at Abbot Laboratories. Beer received his education at The University of Miami (Ohio). Learn more: https://renoviainc.com/leadership/
Renovia, Beer’s latest venture, moves with the mission to design both therapeutic and diagnostic products that aid in the treatment of pelvic floor disorders found in women across the globe. One such example would be urinary incontinence, which affects an estimated 250 million women worldwide. In April 2018, Renovia’s product, Leva, became the company’s first product approved by the FDA. Four additional therapeutic and diagnostic products, including a new generation of Leva, are set to be developed thanks to funding from The Longwood Fund, a healthcare-focused investment firm.
Beer has expressed his excitement about the future of Renovia and its close work with The Longwood Fund, stating, “We are thrilled to have the support of this group of leading healthcare investors who share our vision to better diagnose, treat and improve the lives of millions of women affected by pelvic floor disorders.” Beer appears optimistic about what Renovia’s products will offer to the women of the world. He hopes to give women a more clear-cut diagnosis of their issues and provide the most effective treatment possible. In doing this, Beer also hopes to develop a greater understanding of these disorders and eventually lower healthcare costs to make treatment and diagnosis of pelvic floor disorders more affordable. When considering how many women worldwide there are that have these disorders, without effective and/or affordable treatments, it is easy to see the noble mission that Marc Beer is on, leading Renovia to the future of pelvic floor disorder diagnosis and treatment.